SGRY — Surgery Partners, Inc.

Surgery Partners, Inc. (SGRY) Q4 and Full Year 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Full Year Net Revenue: $3.3 billion, a 6.2% increase year-over-year, but at the low end of expectations.
• Same-Facility Revenue Growth: 4.9%.
• Adjusted EBITDA: $526 million, a 3.5% increase year-over-year, but significantly below expectations.
• Adjusted EBITDA Margin: 15.9%, reflecting a 40 basis point compression.

2. Strategic Updates and Business Highlights

• Surgical Cases: Performed nearly 670,000 surgical cases in 2025, with a 1.3% same-facility case growth.
• Orthopedic Procedures: Over 42,000 orthopedic cases in Q4, with total joint procedures growing 15% in Q4 and 19% year-to-date.
• Physician Recruitment: Nearly 700 physicians recruited in 2025, although transitions impacted payer mix.
• Capital Deployment: $182 million deployed towards acquisitions, slightly below the annual target of $200 million.
• De Novo Facilities: Opened four new facilities in Q4, totaling eight for the year, focusing on higher-acuity specialties.
• Portfolio Optimization: Ongoing efforts to divest or partner with facilities not aligned with core strategies, exemplified by a joint venture with Baylor Scott & White.

3. Forward Guidance and Outlook

• 2026 Preliminary Guidance:
  • Net Revenue: Expected between $3.3 billion and $3.45 billion, indicating single-digit growth.
  • Adjusted EBITDA: Projected at least $530 million, reflecting a growth of at least 0.7%.

4. Bad News, Challenges, or Points of Concern

• Performance Decline: Significant headwinds in Q4, particularly in three surgical hospital markets, led to lower-than-expected case growth and adverse payer mix shifts.
• Margin Compression: Driven by slower case growth and a shift towards a higher Medicare mix, alongside rising labor and anesthesia costs.
• Payer Mix Pressure: Transition of physicians resulted in a higher proportion of Medicare patients, impacting revenue from commercial payers.
• Execution Challenges: Acknowledgment of the need for improved execution and management of operational dynamics.

5. Notable Q&A Insights

• Market Dynamics: Management emphasized that the challenges faced were not systemic but localized to specific markets.
• Future Strategy: Focus on improving free cash flow and reducing leverage while maintaining a disciplined approach to capital allocation.
• Leadership Changes: New COO, Justin Oppenheimer, is tasked with addressing performance issues in underperforming facilities.
• Long-Term Confidence: Despite short-term setbacks, management remains confident in the long-term growth potential and structural integrity of the business model.

This summary encapsulates the key points from the earnings call, highlighting both the financial performance and strategic direction of Surgery Partners, Inc. while addressing the challenges faced during the year.